Cargando…
MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
Conventional high-grade osteosarcoma is the most common primary bone cancer with relatively high incidence in young people. Recurrent and metastatic tumors are difficult to treat. We performed a kinase inhibitor screen in two osteosarcoma cell lines, which identified MEK1/2 inhibitors. These inhibit...
Autores principales: | Baranski, Zuzanna, Booij, Tijmen H., Kuijjer, Marieke L., de Jong, Yvonne, Cleton-Jansen, Anne-Marie, Price, Leo S., van de Water, Bob, Bovée, Judith V. M. G., Hogendoorn, Pancras C.W., Danen, Erik H.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701229/ https://www.ncbi.nlm.nih.gov/pubmed/26807203 |
Ejemplares similares
-
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
por: Baranski, Zuzanna, et al.
Publicado: (2015) -
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
por: Kuijjer, Marieke L, et al.
Publicado: (2014) -
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
por: Kuijjer, Marieke L, et al.
Publicado: (2013) -
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
por: Kuijjer, Marieke L, et al.
Publicado: (2011) -
Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019)